Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
09/2005
09/15/2005US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders
09/15/2005US20050203081 Inhibitors of protein tyrosine phosphatase 1B
09/14/2005EP1572672A1 Benzoxazocines and their use as monoamine-reuptake inhibitors
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668297A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
09/13/2005US6943167 Helix mimetics and composition and methods related thereto
09/13/2005US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005081960A2 Inhibitors of protein tyrosine phosphatase 1b
09/09/2005CA2762878A1 Crystalline forms of a pharmaceutical compound
09/09/2005CA2557541A1 Pyrimidine derivatives
09/08/2005US20050197379 neuroprotective and neuroregenerative compositions; produced by actinomycete strains
09/08/2005US20050197367 Novel bicyclic compounds as modulators of androgen receptor function and method
09/08/2005US20050197359 Bicyclic modulators of androgen receptor function
09/08/2005US20050197333 Rifamycin analogs and uses thereof
09/08/2005US20050197330 Heterocyclic GABAA subtype selective receptor modulators
09/07/2005EP1571151A1 Process for production of O-alkylated rapamycin derivatives
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
09/07/2005EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
09/07/2005EP1377589B1 Oxazolyl-pyrazole derivatives as kinase inhibitors
09/07/2005EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005CN1665513A 1, 3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1217940C Naphthol derivatives
09/06/2005US6939888 Heterocyclic amides such as 3-(2-chloro-6-methoxyphenyl)-5-isopropyl-5-methyl-4-acetoxy-3-pyrrolidine-2 -one, used as insecticides or miticides
09/06/2005US6939882 Fungicides
09/06/2005US6939878 Deuterated rapamycin compounds, method and uses thereof
09/06/2005US6939877 Nitrogen compounds such as 2-(4-benzo[b]thiophen-3-yl-3,6-dihydro-2H-pyridin-1-ylmethyl)-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline, used for prophylaxis of psychological disorders
09/06/2005US6939376 Drug-delivery endovascular stent and method for treating restenosis
09/06/2005CA2193329C Water soluble rapamycin esters
09/06/2005CA2137673C Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives
09/01/2005WO2005080989A1 Biotin recognition sensors and high-throughput assays
09/01/2005WO2005080399A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
09/01/2005WO2005080335A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005WO2005079192A2 Novel treatment
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192311 Process for production of O-alkylated rapamycin derivatives
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050191643 Cyanine compounds and their application as quenching compounds
09/01/2005DE102004001871A1 Tricyclische Benzazepin-Derivate und ihre Verwendung Tricyclic benzazepine derivatives and their use
09/01/2005CA2555812A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005CA2554774A1 Novel heterocyclic compound
08/2005
08/31/2005EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
08/31/2005EP1567165A2 Water-soluble mesoporphyrin compounds and methods of preparation
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1660812A New medical salt and preparation in group of carbostyril mandelate and preparing method
08/30/2005US6936712 Process for the production of oxabispidines
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077958A1 Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-c]thienopyridyl]-(2-chlorophenyl)acetate
08/25/2005WO2005077932A2 Chemokine receptor antagonists
08/25/2005WO2005077925A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077363A1 Heterocyclic gaba-a subtype selective receptor modulators
08/25/2005WO2005058911A3 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
08/25/2005WO2005021515A3 Inhibitors of phosphodiesterase type-iv
08/25/2005US20050187389 Pyrrolo[2,3-d]pyrimidine derivatives; inhibitors of protein tyrosine kinase activity especially modulators of epidermal growth factor receptor; antiproliferative; anticancer; blood vessel growth, benign hyperplasia, keloid formation, psoriasis; (1-Phenylethyl)-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amine
08/25/2005US20050187313 Process for aqueous milling of quinacridone pigments
08/25/2005US20050187267 Nonsteroidal, nontoxic tissue selective modulators for side effect reduction; age-related and androgen-receptor related conditions such as sarcopenia; e.g. 4-(4-Hydroxy-1,1,3-trioxohexahydrothia-2,6a-diazapentalen-2-yl)-2-chloro-3-methylbenzonitrile
08/25/2005US20050183635 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1565475A1 Diazinopyrimidines
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6932961 N-methyl-2-[(1-phenyl-1,2-dihydro[1,4]oxazino[2,3,4-jk]carbazol-7-yl)oxy]-1-ethanamine for example, isotopically labelled; for diagnostic screening using tomography; Central Nervous System (CNS)
08/18/2005WO2005075484A2 Chemokine ccr5 receptor modulators
08/18/2005WO2005063742A3 Amidino compounds as cysteine protease inhibitors
08/18/2005WO2005058888A3 Oxazolidinone-quinolone hybrid antibiotics
08/18/2005US20050182052 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005CA2554671A1 Chemokine ccr5 receptor modulators
08/17/2005EP1562956A2 Fused bicyclic nitrogen-containing heterocycles
08/17/2005EP1562654A1 Medical devices incorporating deuterated rapamycin for controlled delivery thereof
08/17/2005EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
08/17/2005EP0990650B1 Tricyclic pyrrole or pyrazole derivatives
08/17/2005CN1656102A Fused bicyclic pyridine derivative as tachykinin receptor antagonist
08/17/2005CN1656066A Pharmaceutical combination
08/17/2005CN1655833A Medical devices containing rapamycin analogs
08/17/2005CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
08/17/2005CN1654467A N-methyl benzothiazole lifumeisu and method for preparing same
08/16/2005US6930105 Tetracyclicazaindoles and indolines having 5-HT activity
08/11/2005WO2005073238A1 Pyridobenzoxazine derivative
08/11/2005WO2005073237A2 Polymorphic forms of a gabaa agonist
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005US20050176960 Diastereomeric crystallization using a single optically active resolving agent, (S)-10-camphorsulfonic acid, and a solvent; optically pure form
08/11/2005US20050176810 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 220